⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2476934 | 0.88 | — | — | |
| SCHEMBL4872445 | 0.81 | — | — | |
| SCHEMBL3690528 | 0.79 | — | — | |
| SCHEMBL4122875 | 0.78 | — | — | |
| SCHEMBL23660896 | 0.77 | SMPD1 (0.30) | — | |
| SCHEMBL4777139 | 0.77 | SMPD1 (0.30) | — | |
| SCHEMBL18746889 | 0.77 | SMPD1 (0.30) | — | |
| SCHEMBL4725556 | 0.77 | SMPD1 (0.30) | — | |
| SCHEMBL1190984 | 0.77 | SMPD1 (0.30) | — | |
| SCHEMBL20129008 | 0.77 | SMPD1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 606 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092066-A1 | NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | BRISTOL MYERS SQUIBB CO (US) | 2026-04-02 | — | — | US | claimed |
| CN-119822945-A | Hyacinth fragrance compound, preparation method thereof and hyacinth fragrance type fragrance base | 波顿香料股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| EP-3953334-B1 | NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10- {4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15 -(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ONE | BRISTOL MYERS SQUIBB CO (US) | 2023-11-22 | — | — | EP | claimed |
| US-20220144836-A1 | NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | BRISTOL-MYERS SQUIBB COMPANY | 2022-05-12 | — | — | US | claimed |
| US-20160130260-A1 | TERT-BUTYL SULPHOXIDE METHOD FOR PRODUCING FESTINAVIR | BRISTOL MYERS SQUIBB CO (US) | 2016-05-12 | — | — | US | claimed |
| EP-3008060-A1 | TERT-BUTYL-SULPHOXIDE METHOD FOR PRODUCING FESTINAVIR | Bristol-Myers Squibb Company (US) | 2016-04-20 | — | — | EP | claimed |
| WO-2014201122-A1 | TERT-BUTYL-SULPHOXIDE METHOD FOR PRODUCING FESTINAVIR | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-12-18 | — | — | WO | claimed |
| CN-102267993-A | Polyhydroxy desmethyl tropane compounds and preparation method and use thereof | — | 2011-12-07 | — | — | CN | claimed |
| EP-1615904-B1 | SUBSTITUTED BENZOSULPHONAMIDES AS POTENTIATORS OF GLUTAMATE RECEPTORS | ASTRAZENECA AB (SE) | 2008-02-27 | — | — | EP | claimed |
| US-20070021606-A1 | Therapeutic compounds | ASTRAZENECA AB (SE) | 2007-01-25 | — | — | US | claimed |
| EP-1615904-A2 | SUBSTITUTED BENZOSULPHONAMIDE AS POTENTIATORS OF GLUTAMATE RECEPTORS | AstraZeneca AB (SE) | 2006-01-18 | — | — | EP | claimed |
| WO-2004092135-A2 | SUBSTITUTED BENZOSULPHONAMIDE AS POTENTIATORS OF GLUTAMATE RECEPTORS | ASTRAZENECA (SE) | 2004-10-28 | — | — | WO | claimed |
| WO-2026102147-A1 | TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS | Treeline Biosciences, Inc. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | UNIV YALE (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4720071-A1 | COMPOUNDS FOR THE DEGRADATION OF EGFR KINASE | Beone Medicines I GmbH (CH) | 2026-04-08 | — | — | EP | disclosed |
| US-20260092066-A1 | NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE | BRISTOL MYERS SQUIBB CO (US) | 2026-04-02 | — | — | US | disclosed |
| US-4202823-A | DIURETICS | HOFFMANN-LA ROCHE INC. (US) | 1980-05-13 | — | — | US | disclosed |
| US-4180570-A | 17β-Hydroxy-4-androsten-3-ones and process for the preparation thereof | SCHERING AKTIENGESELLSCHAFT (DE) | 1979-12-25 | — | — | US | disclosed |
| EP-0000368-A1 | D-Homosteroids and preparations containing them, processes for the production of such d-homosteroids | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-01-24 | — | — | EP | disclosed |
| US-4129564-A | DIURETICS | SCHERING, A.G. PATENTABTEILUNG (DE) | 1978-12-12 | — | — | US | disclosed |